Researchers developed a urine test that detects bladder cancer, predicts which patients will benefit from immunotherapy ...

A simple urine test devised by researchers at Stanford Medicine and the VA Palo Alto Health Care System can diagnose people ...

A simple urine test developed by researchers at Stanford Medicine and the VA Palo Alto Health Care System can diagnose ...

A new urine test could identify people with bladder cancer more accurately than current diagnostic methods, researchers found.

Resero Bio, a precision diagnostics company building a cell-free RNA (cfRNA) liquid biopsy platform, today announced publication of a Stanford-led study in Nature Medicine demonstrating that analysis ...

Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

Bladder cancer is the abnormal and rapid growth of mutated bladder cells. It starts along the lining of the bladder and progresses through the organ dysreg | Urinary And Excretory System ...

Cancer Research: Unlike most liquid biopsies, which look for cancer-related DNA mutations, RNA analysis reveals which genes ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...

The Bladder Cancer Treatment Market was valued at USD 5.13 Billion in 2025 and is projected to expand at a 9.2% CAGR from ...